scholarly journals The ghrelin-growth hormone axis preserves gluconeogenesis to maintain blood glucose levels during starvation

2012 ◽  
Vol 6 (S3) ◽  
Author(s):  
Daniel P Sherbet ◽  
Tongjin Zhao ◽  
Robert L Li ◽  
Michael S Brown ◽  
Joseph L Goldstein
1993 ◽  
Vol 40 (5-6) ◽  
pp. 204-208
Author(s):  
J. Lebl ◽  
Edith Schober ◽  
H. Frisch ◽  
Susanne Sagmeister ◽  
Gabriele Häusler

2015 ◽  
Vol 112 (4) ◽  
pp. 1226-1231 ◽  
Author(s):  
Yuanyuan Zhang ◽  
Fei Fang ◽  
Joseph L. Goldstein ◽  
Michael S. Brown ◽  
Tong-Jin Zhao

Plasma growth hormone (GH) and hepatic autophagy each have been reported to protect against hypoglycemia in the fasted state, but previous data have not linked the two. Here we demonstrate a connection using a mouse model of fasting in a fat-depleted state. Mice were subjected to 1 wk of 60% calorie restriction, causing them to lose nearly all body fat. They were then fasted for 23 h. During fasting, WT mice developed massive increases in plasma GH and a concomitant increase in hepatic autophagy, allowing them to maintain viable levels of blood glucose. In contrast, lethal hypoglycemia occurred in mice deficient in the GH secretagogue ghrelin as a result of knockout of the gene encoding ghrelin O-acyltransferase (GOAT), which catalyzes a required acylation of the peptide. Fasting fat-depleted Goat−/− mice showed a blunted increase in GH and a marked decrease in hepatic autophagy. Restoration of GH by infusion during the week of calorie restriction maintained autophagy in the Goat−/− mice and prevented lethal hypoglycemia. Acute injections of GH after 7 d of calorie restriction also restored hepatic autophagy, but failed to increase blood glucose, perhaps owing to ATP deficiency in the liver. These data indicate that GH stimulation of autophagy is necessary over the long term, but not sufficient over the short term to maintain blood glucose levels in fasted, fat-depleted mice.


1999 ◽  
Vol 54 (4) ◽  
pp. 135-138
Author(s):  
Joel Faintuch ◽  
Renata B. A. Leme ◽  
Maria Emilia L. F. Cruz ◽  
Angela M. B. Lima ◽  
Daniel Giannella Neto ◽  
...  

Blood glucose levels in the high normal range or even moderate hyperglycemia is the expected profile in septic postoperative patients receiving high-calorie enteral alimentation. The addition of growth hormone as an anabolic agent should additionally reinforce this tendency. In a cancer patient undergoing partial gastrectomy with lymphadenectomy and suffering from postoperative subphrenic abscess and prolonged sepsis, tube feeding (38.3 kcal/kg/day) and growth hormone (0.17 IU/kg/day) were simultaneously administered for 25 days. Blood glucose levels were in the lower limits of the normal range before growth hormone introduction, and continued with a similar tendency during most of the therapeutic period. Two additional complications, namely heart arrest and peripheral edema, were documented during the same period. It is concluded that sepsis was the most likely mechanism for low glucose values, and that high-calorie enteral diet and growth hormone supplementation did not prevent that result. It is uncertain whether heart arrest was due to the drug, but its association with peripheral edema is well documented in clinical series.


The Lancet ◽  
1986 ◽  
Vol 327 (8494) ◽  
pp. 1382 ◽  
Author(s):  
Bonnie Davis ◽  
Kenneth Davis

PEDIATRICS ◽  
1970 ◽  
Vol 45 (1) ◽  
pp. 36-42
Author(s):  
H. Wolf ◽  
P. Stubbe ◽  
V. Šabata

The present investigation was designed to provide information on growth hormone response to changing blood glucose levels in the neonatal period. Three groups of mothers and their infants were studied. The first group consisted of 10 women in labor who received constant glucose infusions, the second group consisted of 10 women who received glucose-insulin infusions; a third group of 20 mothers received no infusion at all. It was shown that the normally high levels of growth hormone in cord blood may be still further elevated by maternal glucose or glucose-insulin infusions shortly before birth. If the utilization and reserves of carbohydrates during the neonatal period are insufficient, high growth hormone levels may help to initiate the mobilization of fat needed to supply energy.


2006 ◽  
Vol 31 (03) ◽  
Author(s):  
H Hager ◽  
E Giorni ◽  
A Felli ◽  
B Mora ◽  
M Hiesmayr ◽  
...  

1972 ◽  
Vol 70 (2) ◽  
pp. 373-384 ◽  
Author(s):  
W. N. Spellacy ◽  
W. C. Buhi ◽  
S. A. Birk

ABSTRACT Seventy-one women were treated with a daily dose of 0.25 mg of the progestogen ethynodiol diacetate. They were all tested with a three-hour oral glucose tolerance test before beginning the steroid and then again during the sixth month of use. Measurements were made of blood glucose and plasma insulin and growth hormone levels. There was a significant elevation of the blood glucose levels after steroid treatment as well as a deterioration in the tolerance curve in 12.9% of the women. The plasma insulin values were also elevated after drug treatment whereas the fasting ambulatory growth hormone levels did not significantly change. There was a significant association between the changes in glucose and insulin levels and the subject's age, control weight, or weight gain during treatment. The importance of considering the metabolic effects of the progestogen component of oral contraceptives is stressed.


Sign in / Sign up

Export Citation Format

Share Document